Core Viewpoint - The nuclear pollution prevention sector is experiencing significant growth, driven by recent events in Japan that have raised global concerns about nuclear safety and pollution management [1][3]. Company Performance - Companies in the nuclear pollution prevention sector have seen substantial stock price increases, with notable performers including: - Puni Testing (谱尼测试) up 19.95% to 9.32 - Zaiseng Technology (再升科技) up 9.97% to 11.03 - Yinbang Shares (银邦股份) up 5.41% to 13.05 - Guangzhi Technology (光智科技) up 5.23% to 48.27 - Hujiang Materials (沪江材料) up 5.14% to 19.23 [2]. Industry Context - The recent leakage incident at Japan's "Puxian" nuclear reactor, which involved approximately 20 milliliters of radioactive water, has highlighted serious vulnerabilities in Japan's nuclear facility operations and safety regulations [3][4]. - The timing of this incident coincides with Japan's controversial decision to release over 130,000 tons of treated nuclear wastewater from the Fukushima plant, which has sparked significant public opposition and international criticism [4][5]. Market Trends - The nuclear pollution prevention industry is expanding, particularly in China, where the growth of nuclear power plants and advancements in nuclear technology are driving demand for pollution management solutions [6]. - The market for nuclear pollution prevention is expected to grow due to increased concerns about radiation and the need for effective waste management technologies [6]. Sector Segmentation - The nuclear pollution prevention industry can be divided into several segments, including: - Nuclear accident prevention - Nuclear waste treatment - Radiation protection - Decommissioning of nuclear facilities [7]. Relevant Companies and Technologies - Key companies and their technologies in the nuclear pollution prevention sector include: - China General Nuclear Power (中广核技) and China Electric Environmental Protection (中电环保) for nuclear wastewater treatment technologies - Jiarong Technology (嘉戎技术) for membrane separation technology applicable to nuclear wastewater treatment - Hailun Zhe (海伦哲) for biochemical decontamination equipment - Jianlong Micro-Nano (建龙微纳) for specialized molecular sieves for radioactive element removal [8]. - Other notable companies include: - Sun Moon Shares (日月股份) for nuclear storage tank products - Tongyu Heavy Industry (通裕重工) for intelligent nuclear waste treatment equipment - China General Nuclear (中国广核) for nuclear wastewater processing capabilities [8].

12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结。 截至本公告日，国合集团持有本公司118,914,273股，占公司总股本的12.58%，为公司持股5%以上股东 而非控股股东，亦非公司控股股东的一致行动人，其所持公司股份被司法冻结不会影响公司的正常生产 经营。 截至本公告日，国合集团持有公司股份累计被冻结118,914,273股，占其所持有的公司股份的100.00%， 占公司总股本的12.58%。 | 股东名称 持股教量（股） 特股比例 | | --- | 据了解，因金融借款纠纷，大连高新技术产业园区人民法院于12月15日申请将国合集团所持中广核技 14,273股、118,900,000股司法冻结，到期日为2028年12月14日。 12月19日，中广核技（000881）公告称，公司于2025年12月17日接到持股5%以上股东中国大连国际经 济技术合作集团有限公司（简称"国合集团"）函告，获悉国合集团所持有本公司的部分股份被司法再冻 结及轮候冻结 ...

Group 1 - Xusheng Group's actual controller has changed to the Guangzhou Municipal Government, with stock resuming trading on December 23, 2025 [1] - Lingyun Light plans to invest up to $5 million in the IPO of Zhipu Hong Kong as a cornerstone investor [1] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuan Robotics to enhance collaboration in the development of dexterous hands [2] Group 2 - Hualian Holdings intends to acquire 100% of the Canadian company Argentum Lithium S.A. for $175 million, which is approximately 1.235 billion yuan [3] - Shiyuan Zhaoye plans to raise no more than 550 million yuan through a convertible bond issuance for the Zhuhai Shiyuan Jingguan Garden project [4] - ST Quanwei and its subsidiary are involved in a civil mediation agreement involving 69.0158 million yuan [4] Group 3 - Jiao Jian Co.'s actual controller has been subjected to criminal coercive measures, but the company's control has not changed [5] - Tianji Technology is facing a lawsuit for alleged collusion in bidding, but its operations remain normal [5] - Jinpan Technology plans to issue 1.672 billion yuan in convertible bonds for data center power modules and other projects [5] Group 4 - Hongqi Chain's shareholder Yonghui Supermarket plans to reduce its stake by up to 3% [6] - Shuangqiang Technology's director did not implement a planned share reduction [7] - Zhuoran Co.'s subsidiary has signed a significant order worth 4.033 billion yuan [8] Group 5 - ST Zhitong's stock will have its risk warning lifted on December 24, 2025, with a change in trading limits [9] - Yingwei Co. plans to reduce its stake by up to 0.56% [10] - Huaxia Happiness's board rejected five temporary proposals from China Ping An Life Insurance [11] Group 6 - China Nonferrous Metals plans to acquire 99.9% of Raura Company for $106 million [11] - Sanhua Intelligent Control expects a net profit of 3.874 billion to 4.649 billion yuan for 2025, a year-on-year increase of 25% to 50% [11] - Chaoxun Communication received a government subsidy of 18.0455 million yuan [12] Group 7 - Jiangfeng Electronics plans to transfer 4% of Shanghai Runping's equity for 60 million yuan [12] - Dingyang Technology has launched a 20 GHz high-bandwidth digital oscilloscope [13] - Linyi Intelligent plans to acquire 35% of Dongguan Liminda Electronics for 875 million yuan [14] Group 8 - Trina Solar has sold its U.S. 5GW module factory to T1, receiving $100 million in cash and shares [14] - Aihua Packaging's major shareholder reduced its stake by 700,000 shares during the stock's abnormal fluctuation period [14] - China Merchants Bank has approved a comprehensive credit limit of 165 billion yuan for China Merchants Group [15] Group 9 - Lingwei Technology plans to acquire 70% of Jiangsu Huimai for 50.2 million yuan [16] - Yongding Co. is increasing its capital by 600 million yuan for its polysilicon subsidiary [19] - Zhong'an Technology's subsidiary is voluntarily extending its share lock-up period by six months [19] Group 10 - Xiangyu Medical's brain-computer interface products have entered over 500 top-tier hospitals, with a target of 700 by the Spring Festival [18] - Wenda Technology's major shareholder has terminated its share reduction plan [18] - Wenta Technology's major shareholder reduced its stake by 1.2097 million shares [18]

Group 1 - Rongchang Biotech plans to repurchase shares worth between 20 million and 40 million yuan, with a maximum price of 95 yuan per share, aiming to buy back approximately 21,050 to 42,110 shares, representing about 0.04% to 0.07% of total share capital [1] - Nanya New Materials intends to raise no more than 900 million yuan through a private placement for AI computing power-based high-frequency high-speed copper-clad laminate R&D and working capital [2] - Xiechuang Data has signed a strategic cooperation agreement with Ping An Financial Leasing, aiming for a cooperation scale of 2 billion yuan over three years [3] Group 2 - Chuangshi Technology's controlling shareholder is under investigation and has been placed under detention, having resigned from all positions in the company [4] - Deep Kangjia A has reported overdue shareholder loans to Yikang Technology and Chuzhou Kangxin, totaling approximately 233 million yuan and 395 million yuan respectively, due to repayment issues [5] - Ningbo Yuanyang announced the resignation of two directors due to work adjustments [6] Group 3 - China Merchants Energy has delivered the world's first methanol dual-fuel VLCC oil tanker, with 15 oil tanker orders in hand [7] - Tianyu Co., Ltd. has received a drug registration certificate for hydrochloride trazodone tablets, which are used for treating depression [8] - Haizheng Pharmaceutical has received FDA approval for clinical trials of HS387 tablets for treating advanced solid tumors [9] Group 4 - Warner Pharmaceuticals has obtained a drug registration certificate for isoproterenol hydrochloride injection, used for treating shock and complete atrioventricular block [10] - Hekang New Energy's subsidiary received a government subsidy of 1.5 million yuan, which accounts for 14.57% of the company's latest audited net profit [11] - Duku Culture is planning a change in company control, with stock suspension expected for no more than two trading days [12] Group 5 - Haisco has received acceptance for an IND application for HSK46575 tablets for prostate cancer treatment [13] - *ST Xinyan is executing a capital reserve transfer to increase share capital, resulting in a stock suspension [14] - Nanjing Public Utilities is transferring a 45% stake in a subsidiary for 23.6443 million yuan [15] Group 6 - Action Education plans to repurchase shares worth between 20 million and 25 million yuan, with a maximum price of 45 yuan per share [16] - Bai'ao Tai has received government subsidies totaling 29 million yuan [18] - Weisi Medical intends to sell assets worth 119 million yuan, expecting a profit impact of approximately 10 million yuan [19] Group 7 - Tongyu Communications plans to increase capital by 10 million yuan to introduce investment from Wuchuang Institute [20] - Dongtu Technology's subsidiary is introducing strategic investor Guofeng Investment Fund with a capital increase of 11 million yuan [21] - China General Nuclear Power Technology's shareholder is facing a judicial auction of 2.91% of the company's shares [22] Group 8 - Nanshan Aluminum plans to repurchase shares worth between 300 million and 600 million yuan, with a maximum price of 7.52 yuan per share [23] - Yipin Hong's controlling shareholder has committed to transferring 9.07% equity in Arthrosi without compensation [24] - Sanli Pharmaceutical has signed a technology transfer contract worth 200 million yuan with Hainan University [25] Group 9 - Xin Nuo Wei plans to jointly invest 450 million yuan with Zhongqi Pharmaceutical to establish a joint venture focusing on innovative metabolic drugs [26] - Li Qun Co. has been approved to issue 1 billion yuan in medium-term notes to optimize debt structure and supplement working capital [27] - Dongfang Ocean's subsidiary has received a medical device registration certificate for a procalcitonin test kit [28] Group 10 - Tibet Mining's chairman has resigned due to work adjustments [29] - Wantai Biological's subsidiary has been shortlisted for a national immunization program vaccine procurement project, with a bid price of 27.5 yuan [30] - Xingfu Blue Sea has appointed Zhang Chen as the new deputy general manager [31] Group 11 - Changyuan Donggu has elected Li Yixuan as the vice chairman of the board [32] - Ningbo Huaxiang's subsidiary has signed a strategic cooperation agreement with Dahuang Robotics for collaboration in humanoid robot development [33] - Yongda Co. has been pre-selected for a procurement project worth approximately 350 million yuan [34] Group 12 - Fuan Pharmaceutical's subsidiary has received a drug registration certificate for hydrochloride trazodone tablets [35] - Nanjing Food reported a 71.03% year-on-year decrease in net profit for November due to rising raw material costs [36] - Changqing Technology's special polymer monomer project has commenced production [37]

证券代码：000881 证券简称：中广核技 公告编号：2025-056 中广核核技术发展股份有限公司 关于持股 5%以上股东部分股份将被司法拍卖的进展 公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别风险提示： 截至本公告日，中国大连国际经济技术合作集团有限公司（以下简称"国 合集团"）持有本公司 118,914,273 股，占公司总股本的 12.58%，为公司持股 5%以上股东而非控股股东，亦非公司控股股东的一致行动人，其所持公司部分 股份被司法拍卖不会影响公司的正常生产经营。 2025 年 10 月 28 日，中广核核技术发展股份有限公司（以下简称"公司"） 在 《 中 国 证 券 报 》 《 上 海 证 券 报 》 《 证 券 时 报 》 和 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露了《关于持股 5%以上股东部分股份将被司法拍 卖的公告》（公告编号 2025-050）。近日，公司接到国合集团通知，根据大连高 新技术产业园区人民法院的《拍卖通知书》，国合集团所持有本公司的 2,750 万 股股份将于 202 ...

中广核技公告，持股5%以上股东国合集团所持有公司的2750万股股份将于2026年1月22日至2026年1月 23日止在京东网拍卖，占其所持股份比例的23.13%，占公司总股本的2.91%。国合集团不是公司的控股 股东，其所持股份被司法拍卖不会影响公司的正常生产经营。 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-055 中广核核技术发展股份有限公司 关于董事会换届选举的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会将于 2026 年 1 月任期届满。为顺利完成董事会的换届选举（以下简称"本次换届选举"）， 公司董事会根据《中华人民共和国公司法》《上市公司独立董事管理办法》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》《公司章 程》等有关规定，现将十一届董事会董事候选人提名、本次换届选举程序、董事 任职资格等事项公告如下： 一、董事候选人提名 1、非独立董事候选人提名 公司董事会及本公告发布之日单独或合并持有公司 1%以上股份的股东有权 向第十届董事会提名推荐第十一届董事会非独立董事候选人。单个提名人提名的 非独立董事人数不得超过本次拟选的非独立董事总人数。 2、独立董事候选人提名 公司董事会及本公告发布之日单独或合并持有公司 1%以上股份的股东有权 向第十届董事会提名推荐第十一届董事会独立董事候选人。单 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-054 关于持股 5%以上股东股份被冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 特别风险提示： 1.截至本公告日，中国大连国际经济技术合作集团有限公司（以下简称"国合集团"） 持有本公司 118,914,273 股，占公司总股本的 12.58%，为公司持股 5%以上股东而非控股股 东，亦非公司控股股东的一致行动人，其所持公司股份被司法冻结不会影响公司的正常生 产经营。 2.截至本公告日，国合集团持有公司股份累计被冻结 118,914,273 股，占其所持有的公 司股份的 100.00%，占公司总股本的 12.58%。 中广核核技术发展股份有限公司（以下简称"公司"）于 2025 年 12 月 17 日接到持股 5%以上股东国合集团函告，获悉国合集团所持有本公司的部分股份 被司法再冻结及轮候冻结，具体事项如下： 一、国合集团持有公司股份被冻结的基本情况 | 股东名 称 | 是否为控 股股东或 第一大股 | 本次冻结股 | 占其 所持 | 占公 司总 | 是否为限 售股及限 | 起始 ...

Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (CGN Tech) announced that as of December 17, 2025, a significant shareholder, Guohe Group, has had part of its shares judicially frozen due to a financial loan dispute [1] Group 1: Shareholder Information - Guohe Group holds 119 million shares of CGN Tech, representing 12.58% of the total share capital [1] - The total number of frozen shares is 119 million, which accounts for 100% of Guohe Group's holdings in CGN Tech and 12.58% of the total share capital [1] Group 2: Legal and Operational Impact - The shares frozen are related to the lock-up shares post-initial public offering (IPO) [1] - The freezing of shares is executed by the Dalian High-tech Industrial Park People's Court, but it does not affect the normal production and operation of CGN Tech [1]

Group 1 - The mechanical sector has shown strong performance in 2025, with the Shenwan Mechanical Equipment Index rising by 36.11%, outperforming the Shanghai Composite Index by 19.74 percentage points and the Shenzhen Component Index by 8.78 percentage points [4][16][19] - In the first three quarters of 2025, the mechanical industry reported revenues of 15,135.34 billion yuan, a year-on-year increase of 7.35%, and a net profit attributable to shareholders of 1,080.76 billion yuan, up 16.80% year-on-year [4][22][27] - The public fund allocation ratio for the mechanical equipment sector increased by 0.25 percentage points in Q3 2025 compared to Q3 2024, indicating improved fundamentals and positive policy impacts [29] Group 2 - The equipment manufacturing industry has maintained export resilience, with significant growth in new overseas markets. From January to October 2025, the export delivery value of general equipment, specialized equipment, and transportation equipment reached 6,173.20 billion yuan, 5,319.30 billion yuan, and 4,124 billion yuan respectively, with year-on-year growth rates of 5.5%, 9.3%, and 24.20% [5][33][36] - The overseas sales of engineering machinery continued to grow, with a year-on-year increase of 11.84% in export value from January to October 2025, driven by technological innovation and diversified market strategies [37][41] - The motorcycle industry has established a strong competitive advantage in overseas markets, with exports reaching 1,101.85 million units and 7.278 billion USD in value from January to October 2025, reflecting a year-on-year increase of 22.28% and 28.2% respectively [42][43] Group 3 - The emergence of new manufacturing scenarios signifies a profound transformation from "single technology upgrades" to "systematic ecological restructuring," enhancing production efficiency, product quality, and innovation capabilities [5][46] - Human-shaped robots are expected to address customization challenges in traditional manufacturing, with a market space projected to expand significantly as they transition from industrial applications to household use [47][54] - The intelligent logistics equipment market in China is expected to grow rapidly, with a projected market size of 1,261 billion yuan in 2025, driven by advancements in IoT and AI technologies [64][72]